loading
Schlusskurs vom Vortag:
$8.24
Offen:
$8.25
24-Stunden-Volumen:
2.03M
Relative Volume:
1.52
Marktkapitalisierung:
$474.93M
Einnahmen:
$1.02B
Nettoeinkommen (Verlust:
$-757.20M
KGV:
-0.5928
EPS:
-14.76
Netto-Cashflow:
$-257.90M
1W Leistung:
+56.31%
1M Leistung:
+28.09%
6M Leistung:
-12.00%
1J Leistung:
+4.76%
1-Tages-Spanne:
Value
$8.16
$9.28
1-Wochen-Bereich:
Value
$5.615
$9.28
52-Wochen-Spanne:
Value
$4.02
$13.28

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Firmenname
Emergent Biosolutions Inc
Name
Telefon
240-631-3200
Name
Adresse
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Mitarbeiter
900
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
EBS's Discussions on Twitter

Vergleichen Sie EBS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
8.75 327.30M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.53 64.93B 9.39B 2.61B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.45 45.07B 29.98B 958.27M 5.31B 0.2964
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.52 41.53B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.37 18.37B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
304.04 13.68B 2.99B 1.21B 1.13B 25.06

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-30 Eingeleitet H.C. Wainwright Buy
2024-08-22 Eingeleitet Rodman & Renshaw Buy
2024-03-07 Hochstufung The Benchmark Company Hold → Buy
2023-11-20 Fortgesetzt JP Morgan Underweight
2023-08-29 Herabstufung The Benchmark Company Buy → Hold
2023-04-10 Hochstufung The Benchmark Company Hold → Buy
2023-03-17 Herabstufung JP Morgan Neutral → Underweight
2022-11-10 Herabstufung The Benchmark Company Buy → Hold
2022-04-29 Herabstufung Cantor Fitzgerald Overweight → Neutral
2022-01-20 Hochstufung The Benchmark Company Hold → Buy
2021-11-08 Herabstufung The Benchmark Company Buy → Hold
2021-05-05 Herabstufung Argus Buy → Hold
2021-04-07 Eingeleitet The Benchmark Company Buy
2021-02-24 Hochstufung Chardan Capital Markets Neutral → Buy
2021-02-19 Herabstufung Chardan Capital Markets Buy → Neutral
2021-01-08 Herabstufung Wells Fargo Overweight → Equal Weight
2020-09-14 Fortgesetzt JP Morgan Neutral
2020-07-31 Bestätigt Chardan Capital Markets Buy
2019-09-12 Eingeleitet Guggenheim Buy
2019-09-04 Hochstufung Wells Fargo Market Perform → Outperform
2018-11-02 Hochstufung Goldman Neutral → Buy
2018-08-03 Bestätigt Chardan Capital Markets Buy
2018-06-13 Eingeleitet Argus Buy
2018-04-25 Herabstufung Wells Fargo Outperform → Market Perform
2018-01-24 Eingeleitet Goldman Neutral
2018-01-16 Bestätigt Chardan Capital Markets Buy
2016-06-28 Bestätigt Singular Research Buy
2016-04-15 Eingeleitet Chardan Capital Markets Buy
2016-03-28 Eingeleitet Singular Research Buy
2016-02-19 Eingeleitet Wells Fargo Outperform
2014-05-15 Eingeleitet Summer Street Research Buy
2011-05-31 Bestätigt WBB Securities Strong Buy
2011-01-10 Bestätigt Wedbush Outperform
2010-11-05 Bestätigt Wedbush Outperform
2010-08-18 Hochstufung WBB Securities Buy → Strong Buy
2010-08-06 Bestätigt Caris & Company Buy
Alle ansehen

Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten

pulisher
12:18 PM

Emergent BioSolutions Updates FY25 Revenue Guidance to $765M-$835M - AInvest

12:18 PM
pulisher
Aug 07, 2025

BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd - Law360

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions Surpasses Q2 Revenue Expectations - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions reports second quarter loss - Maryland Daily Record

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions shares rise 6.14% premarket after securing $51.9 million contract modification for smallpox preparedness. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Installed Building Products reports record Q2 2025 results, 3.1% revenue increase. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent Biosolutions: Q2 Earnings Snapshot - Huron Daily Tribune

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions Inc. SEC 10-Q Report - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Emergent BioSolutions Q2 2025 results show mixed performance - Investing.com

Aug 07, 2025
pulisher
Aug 07, 2025

Emergent BioSolutions Reports Improved Q2 2025 Results - TipRanks

Aug 07, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Outpaces Its Own Forecasts But Misses Analyst Targets - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent Biosolutions earnings beat by $0.26, revenue fell short of estimates - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Q2 2025 slides: Profitability improves as transformation continues - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent Biosolutions Q2 Earnings: Non-GAAP EPS Beats by $0.65, Revenue Misses by $5.47M - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Emergent BioSolutions Reports Second Quarter 2025 Financial Results - The Manila Times

Aug 06, 2025
pulisher
Aug 04, 2025

Emergent BioSolutions Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

Aug 04, 2025
pulisher
Aug 03, 2025

What drives Emergent BioSolutions Inc. stock priceInvest confidently with real-time data analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Emergent BioSolutions Inc. stockMaximize your portfolio’s growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Emergent BioSolutions Inc. as a “Buy”Strong return on assets - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What catalysts could drive Emergent BioSolutions Inc. stock higher in 2025Access high-yield investment alerts now - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is Emergent BioSolutions Inc. stock overvalued or undervaluedTriple returns potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why is Emergent BioSolutions Inc. stock attracting strong analyst attentionInvest smarter and grow your wealth faster - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

What are the technical indicators suggesting about Emergent BioSolutions Inc.Stock Market Ideas With Proven Results - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Insider Sellers Might Regret Selling Emergent BioSolutions Shares at a Lower Price Than Current Market Value - simplywall.st

Aug 01, 2025
pulisher
Jul 30, 2025

What institutional investors are buying Emergent BioSolutions Inc. stockPost Market Outlook For Every Investor - Jammu Links News

Jul 30, 2025
pulisher
Jul 30, 2025

Why Emergent BioSolutions Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Can Emergent BioSolutions Inc. recover in the next quarterReal-Time Analysis With Entry Targets In Progress - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Emergent BioSolutions Inc. Recovery Hinges on Volume BreakoutPotential Breakout Stock List Published This Week - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Investors Hope for Bounce in Emergent BioSolutions Inc. After SelloffAI Based High Gain Watchlist Scanner Shared - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Can Emergent BioSolutions Inc. Regain Momentum After BreakdownCapital Growth With Controlled Risk Picks Suggested - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 03:10:46 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Emergent BioSolutions (EBS) Applauds Naloxone Accessibility in U - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives - The Manila Times

Jul 28, 2025
pulisher
Jul 28, 2025

Emergent BioSolutions Publishes Review on Brincidofovir for Mpox Treatment in Expert Review of Anti-infective Therapy - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

U.S. House Takes Historic Step: NARCAN Now Available in Every Building to Prevent Opioid Deaths - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Emergent BioSolutions Inc. in the next 12 monthsFree Stock Selection - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 04:58:37 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Emergent BioSolutions Inc. stock compared to the marketRecord-breaking gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Emergent BioSolutions Inc. company’s balance sheetMaximize returns with strategic stock selection - Jammu Links News

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Emergent BioSolutions Inc. stockExponential wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Emergent BioSolutions Inc. a good long term investmentHigh-yield growth strategies - PrintWeekIndia

Jul 25, 2025

Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$26.79
price up icon 0.70%
$16.47
price down icon 0.09%
$9.565
price up icon 2.03%
drug_manufacturers_specialty_generic RDY
$13.77
price up icon 1.18%
$124.39
price down icon 0.96%
$304.05
price up icon 1.45%
Kapitalisierung:     |  Volumen (24h):